➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Patent: 10,005,783

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,005,783

Title:	Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
Abstract:	Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.
Inventor(s):	Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Boulder, CO)
Assignee:	Array BioPharma Inc. (Boulder, CO)
Application Number:	15/399,389
Patent Claims:	see list of patent claims

Details for Patent 10,005,783

Subscribe to access the full database, or Free Forever Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	RITUXAN	rituximab	SOLUTION;INTRAVENOUS	103705	001	1997-11-26	⤷ Free Forever Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX		search
Genentech	RITUXAN	rituximab	SOLUTION;INTRAVENOUS	103705	002	1997-11-26	⤷ Free Forever Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX		search
Genentech	HERCEPTIN	trastuzumab	VIAL; INTRAVENOUS	103792	001	1998-09-25	⤷ Free Forever Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX	Orphan	search
Genentech	PERJETA	pertuzumab	VIAL; SINGLE-USE	125409	001	2012-06-08	⤷ Free Forever Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX		search
Genentech	KADCYLA	ado-trastuzumab emtansine	VIAL; SINGLE-USE	125427	001	2013-02-22	⤷ Free Forever Trial	Array BioPharma Inc. (Boulder, CO)	2028-10-22	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,005,783

Subscribe to access the full database, or Free Forever Trial
Country	Patent Number	Estimated Expiration
Argentina	074052	⤷ Free Forever Trial
Argentina	112833	⤷ Free Forever Trial
Australia	2009308465	⤷ Free Forever Trial
Australia	2015200511	⤷ Free Forever Trial
Australia	2017268517	⤷ Free Forever Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Mallinckrodt

Colorcon

Moodys

Dow

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.